Twist Bioscience Corp
TWST
Market Cap$1.64B
Close$
$42.26
37.4% upside
Current Fair Value
37.4% upsideUndervalued by 37.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.64 Billion |
|---|---|
| Enterprise Value | $1.33 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.89 |
| Outstanding Shares | 57,818,022 |
| Avg 30 Day Volume | 761,442 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.97 |
|---|---|
| PEG | -281.45 |
| Price to Sales | 7.69 |
| Price to Book Ratio | 3.08 |
| Enterprise Value to Revenue | 5.06 |
| Enterprise Value to EBIT | -6.48 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Twist Bioscience Corp
CEO: Emily Leproust Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...